Trial Outcomes & Findings for Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition (NCT NCT02227329)

NCT ID: NCT02227329

Last Updated: 2017-12-12

Results Overview

The most common complication in parenteral nutrition is catheter-related blood stream infection (CRBSI), which can lean to increased morbidity, mortality, and prolonged hospitalizations. CRBSI was defined as bacteremia or fungemia in a patient who had an intravascular device and \>1 positive blood culture result obtained from the peripheral vein, clinical manifestations of infection (e.g., fever, chills, and/or hypotension), and no apparent source for blood stream infection other than the central venous catheter.

Recruitment status

TERMINATED

Study phase

PHASE1/PHASE2

Target enrollment

39 participants

Primary outcome timeframe

1 year

Results posted on

2017-12-12

Participant Flow

This clinical trial was carried out from July 2014 to April 2016 at the Mayo Clinic in Rochester, Minnesota.

39 subjects were consented, but one subject was excluded after enrollment due to incompatibility with ongoing treatment (ongoing metronidazole use).

Participant milestones

Participant milestones
Measure
Ethanol Lock and Normal Saline
All patients randomized to the ELT group will receive 3ml of 70% ethanol and saline flush.
Heparin and Normal Saline
All patients randomized to this group will receive Heparin lock (3 mL of 100 U/ml heparin) + saline infusion (current standard of care).
Overall Study
STARTED
18
20
Overall Study
COMPLETED
18
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ethanol Lock and Normal Saline
n=18 Participants
All patients randomized to the ELT group will receive 3ml of 70% ethanol and saline flush.
Heparin and Normal Saline
n=20 Participants
All patients randomized to this group will receive Heparin lock (3 mL of 100 U/ml heparin) + saline infusion (current standard of care).
Total
n=38 Participants
Total of all reporting groups
Age, Continuous
49 years
STANDARD_DEVIATION 16 • n=5 Participants
52 years
STANDARD_DEVIATION 16 • n=7 Participants
51 years
STANDARD_DEVIATION 15 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
14 Participants
n=7 Participants
26 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Region of Enrollment
United States
18 Participants
n=5 Participants
20 Participants
n=7 Participants
38 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 year

The most common complication in parenteral nutrition is catheter-related blood stream infection (CRBSI), which can lean to increased morbidity, mortality, and prolonged hospitalizations. CRBSI was defined as bacteremia or fungemia in a patient who had an intravascular device and \>1 positive blood culture result obtained from the peripheral vein, clinical manifestations of infection (e.g., fever, chills, and/or hypotension), and no apparent source for blood stream infection other than the central venous catheter.

Outcome measures

Outcome measures
Measure
Ethanol Lock and Normal Saline
n=18 Participants
All patients randomized to the ELT group will receive 3ml of 70% ethanol and saline flush.
Heparin and Normal Saline
n=20 Participants
All patients randomized to this group will receive Heparin lock (3 mL of 100 U/ml heparin) + saline infusion (current standard of care).
Number of Catheter-Related Blood Stream Infections
4 infections
1 infections

Adverse Events

Ethanol Lock and Normal Saline

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Heparin and Normal Saline

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Ethanol Lock and Normal Saline
n=18 participants at risk
All patients randomized to the ELT group will receive 3ml of 70% ethanol and saline flush.
Heparin and Normal Saline
n=20 participants at risk
All patients randomized to this group will receive Heparin lock (3 mL of 100 U/ml heparin) + saline infusion (current standard of care).
Infections and infestations
Catheter-related bloodstream infection
22.2%
4/18 • Number of events 4 • 1 year
5.0%
1/20 • Number of events 1 • 1 year

Additional Information

Dr. Ryan Hurt

Mayo Clinic

Phone: 507-284-4461

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place